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To my Family 
 
 ABSTRACT 
Background 
Fetal environment has become a subject for increasing interest when studying health 
and disease in adults. Monozygous (MZ) twins, especially gestations complicated with 
twin-twin transfusion syndrome (TTTS), offer a unique opportunity to study adverse 
developmental programming of the cardiovascular system. TTTS affects about 10 % of 
pregnancies with a common placenta, because of unbalanced blood flow across deep 
arteriovenous connecting vessels. The divergent hemodynamic loads of the donor and 
the recipient fetus often result in myocardial hypertrophy of the recipient heart.  
The aims of this thesis were to evaluate intrauterine environmental contributions to 
vascular functions in twins with discordant birth weight (Paper I), to study long term 
effects of TTTS on cardiac structure and function (Papers II and IV) and to determine 
infant survival and neonatal outcome after fetoscopic laser coagulation therapy of 
TTTS in Sweden (Paper III). 
Methods and Results 
An observational study of 31 twin-pairs, mean age eight years, with discordant weight 
at birth, showed that systolic blood pressure (SBP) was higher and endothelial function 
lower in the smaller twin. In MZ twins with a history of TTTS (n= 9 pairs), there was 
no significant difference in SBP, but donor twins had narrower carotid arteries than 
recipient twins and carotid strain was higher (Paper I).  
Echocardiography of eleven TTTS twin-pairs, mean age 9.6 years, prenatally treated 
with amnioreductions, showed no difference in cardiac structure, but recipients had 
significantly lower diastolic ventricular filling compared with donors (Paper II). When 
examining a laser treated cohort of 19 TTTS twin-pairs, mean age 4.5 years, and 19 
age-matched singleton controls, we found signs of a minor decrease in early diastolic 
ventricular filling in recipients compared with donors, but no differences in heart 
function or structure compared with controls (Paper IV).  
From a hospital-based register of the first Swedish cohort of laser treated TTTS 
pregnancies (n = 71), we found that overall survival from treatment to one year of age 
was 46 %, and that in 61 % of gestations, at least one twin survived infancy. Mean 
gestational age at birth was 30 weeks and mechanical ventilation was needed in 46 % 
of liveborn twins (Paper III). 
Conclusions 
Exposure to fetal growth retardation may contribute to higher blood pressure, arterial 
narrowing and endothelial dysfunction in childhood (Paper I). Fetal and infant survival 
after fetoscopic laser coagulation of TTTS is still limited. If very preterm delivery is 
necessary, the neonatal team has to prepare for taking care of two high-risk neonates 
most likely requiring respiratory support (Paper III). Despite different and severe fetal 
cardiac loading conditions, our long-term follow-up studies of twins surviving TTTS 
showed an overall cardiac structure and function within normal range. The signs of 
reduced diastolic function found in the group treated with amnioreductions (Paper II) 
were less pronounced in the laser treated cohort (Paper IV). 
These observations indicate that the cardiac morbidity caused by TTTS resolves in 
childhood. This has important implications as clinical decision making in TTTS 
frequently involves choosing between accepting increased fetal cardiac morbidity in the 
recipient twin and delivering two very preterm babies. 
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 LIST OF ABBREVIATIONS 
AA Abdominal aorta 
AAA Arterioarterial anastomosis 
ACh Acetylcholine 
AGA Appropriate-for-gestational age 
AoV Aortic valve 
AV atrioventricular 
AVA Arteriovenous anastomosis 
A wave Late (atrial) peak diastolic filling wave measured with 
Doppler flow 
a’ Late (atrial) peak diastolic myocardial movement 
measured with DTI 
BHC Birth head circumference 
BL Birth length 
BP Blood pressure 
BPD Bronchopulmonary dysplasia 
BSA Body surface area 
BW Birth weight 
CCA Common carotid artery 
CVD Cardiovascular disease 
DA Diamniotic 
DBP Diastolic blood pressure 
DC Dichorionic 
DOHaD Developmental origins of health and disease 
DTI Doppler tissue imaging 
DVP Deepest vertical pocket 
DZ Dizygous 
E wave Early peak diastolic filling wave measured with Doppler 
flow 
EDV End diastolic volume 
ESV End systolic volume 
ET Ejection time 
e’ Early peak diastolic myocardial movement measured with 
DTI 
IMTc Intima-media thickness of carotid artery 
IVCT Isovolumetric contraction time 
IVH Intraventricular hemorrhage 
IVRT Isovolumetric relaxation time 
IVS Interventricular septum 
FLOC Fetoscopic laser occlusive coagulation  
GA Gestational age 
LV long SF Longitudinal shortening fraction of left ventricle 
LV maj Left ventricular longitudinal end-diastolic diameter  
LVED Left ventricular end-diastolic diameter 
LVOT Left ventricular outflow tract 
LVPW Left ventricular posterior wall 
MA Monoamniotic 
MAPSE Mitral annular plane systolic excursion 
MC Monochorionic 
MPI Myocardial performance index 
MV Mitral valve 
MZ Monozygous 
PDA Patent ductus arteriosus 
PPHN Persistent pulmonary hypertension of the newborn 
PU Perfusion unit 
PV Pulmonary valve 
RDS Respiratory distress syndrome 
ROP Retinopathy of the premature  
RVAW Right ventricular anterior wall 
RV long SF Longitudinal shortening fraction of right ventricle 
RV maj Right ventricular longitudinal end-diastolic diameter  
RVOT Right ventricular outflow tract 
RVOTO Right ventricular outflow tract obstruction 
SBP Systolic blood pressure 
SF Shortening fraction 
SGA Small-for-gestational age 
STE Speckle tracking echocardiography 
SV Stroke volume 
TAPS Twin-anemia-polycythemia sequence 
TAPSE Tricuspid annular plane systolic excursion 
TTTS Twin-twin transfusion syndrome  
TV Tricuspid valve 
Vmax Peak velocity 
VTI Velocity time integral 
VVA Venovenous anastomosis 
VVI Velocity vector imaging 
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1 INTRODUCTION 
Cardiovascular disease (CVD) is estimated to account for one third of the total 
mortality in the world. The World Health Organisation (WHO) recently developed a 
CVD action plan where objectives included interventions to reduce the burden of major 
CVD risk factors such as smoking, unhealthy diet, harmful use of alcohol and physical 
inactivity. However, risk factors for CVD originating in the perinatal period are less 
known to the public. Due to improvements of fetal and neonatal care, the group of 
neonates surviving a complicated perinatal period is increasing, and the gap in 
knowledge on adverse fetal environmental effects on later health and disease has 
emerged as an important research field.  
 
Monozygous (MZ) twin gestations complicated with twin-twin transfusion syndrome 
(TTTS) or discordant fetal growth offer unique opportunities to study different fetal 
environmental effects on later development. TTTS affects about 10 % of 
monochorionic (MC) pregnancies, with an overall incidence of less than 0.1 % [1].  
 
In the 1990’s, a cohort of twin pregnancies was prospectively collected at the maternal 
and obstetrical unit of Södersjukhuset in Stockholm. The TTTS pregnancies, a special 
clinical challenge, were at that time offered treatment with amnioreductions and 
indomethacin in order to reduce the risk for preterm delivery. Since there was a lack of 
data on TTTS long term outcome I was, as a neonatologist with a special interest in 
pediatric cardiology, asked to do a pediatric follow-up of this cohort. As the 
recommended fetal treatment gradually changed from amnioreductions to laser 
coagulation of placental anastomoses, there was a need for follow-up of this new fetal 
therapy as well.  
2 
2 BACKGROUND 
2.1 DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE 
After decades of discussions about either genetic or environmental factors’ influence on 
the development of the human phenotype, most researchers agree on the importance of 
both. The DOHaD (developmental origins of health and disease) concept focuses on 
how the environment during early human development interacts with the genome to 
influence health in later life. To be able to understand potential health consequences of 
fetal exposures to adverse intrauterine environment, many researchers have studied 
offspring of gestations with perinatal complications, e.g. growth disturbances, preterm 
birth and maternal disease during pregnancy. Scandinavian researchers followed by 
David Barker were among the first to present associations between low birth weight 
and increased risk for hypertension, ischemic heart disease and diabetes in adulthood 
[2, 3]. To disentangle environmental and genetic contributions to early development, 
multiple pregnancies – sharing genetic and early familial conditions – have been used 
as a model for research purposes.  
 
2.2 MULTIPLE PREGNANCY 
The rate of multiple pregnancies varies around the world, representing about 1-3% of 
all pregnancies. In Sweden, the reported multiple birth rate has been 1.5 % during the 
past decade. Of these, triplets and quadruplets represent < 2 % [4]. 
2.2.1 Zygosity- chorionicity 
Zygosity of a twin gestation depends on if the fetuses come from one or two fertilized 
eggs; one egg = monozygous (MZ), two eggs = dizygous (DZ). The DZ gestation is 
usually dichorionic (DC) – i.e. there are two placentas, although these can sometimes 
be fused and on fetal scans appear to be monochorionic (MC). The development of 
chorionicity in a MZ gestation is dependent of the time for cell division. An early 
division of the ovum (< 60 hours from conception) results in a DC pregnancy with 
different amniotic cavities, i.e. diamniotic (DA). When division occurs after 3-8 days, 
the pregnancy will become MC DA, whereas a late cell division (> 8 days) will 
generate MC twins in a common amniotic cavity, i.e. monoamniotic (MA). Very rarely, 
the fertilized cell divides after more than 14 days, and then the twins become conjoined 
or “siamese” [5], Figure 1. 
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Figure 1. Chorionicity in relation to time from fertilization to cell division. Modified 
and published with permission [6]. 
 
When a twin pregnancy is discovered, determination of chorionicity is of major 
importance as MC placentation is considered a malformation and combined with a 
higher risk for complications than the DC. With ultrasound scanning, chorionicity is 
easiest determined in the first trimester, by searching for a lambda (DC) or a T-sign 
(MC) at the membrane-placenta interface [7]. MC occurs in 20 % of all twin 
pregnancies and in 70 % of MZ pregnancies [1]. Growth discordances, congenital 
malformations, acute and chronic transfusions are known complications of MC 
gestations [1].  
2.3 TWIN-TWIN TRANSFUSION SYNDROME (TTTS) 
Twin-twin transfusion syndrome (TTTS) is usually evident in the first or second 
trimester as a pronounced discordance of amniotic fluid volume [8]. TTTS is one of the 
most severe fetal complications carrying an incidence of about 10 % of all MC 
pregnancies and carrying a mortality of 80 % if untreated [8, 9]. In a normal MC 
gestation, there are communicating vessels (anastomoses) in the common placenta, 
linking circulations of the twin fetuses. Depending on the number and types of present 
anastomoses, the exchange of blood may be balanced or unbalanced. TTTS occurs 
when the net transfusion from one twin (the donor) exceeds the flow from the other 
twin (the recipient). The transfusions through deep arteriovenous anastomoses (AVA) 
to the recipient twin, are then insufficiently compensated by the flow through 
superficial venovenous (VVA) and arterioarterial (AAA) anastomoses [10], Figure 2. 
The AVA number has been suggested to be of inferior importance compared with the 
size of anastomoses [11]. TTTS usually presents during the first trimester. The earlier 
the presentation, the poorer the prognosis [12]. To evaluate the severity and eventual 
progress of TTTS, staging according to Quintero is well established, [13], Table 1. 
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Figure 2. TTTS placenta with insertions of donor (DON) and recipient (REC) 
umbilical cords and color dye injected arteriovenous (AVA) and venovenous (VVA) 
anastomoses. Note the larger vessels of the recipient placenta territory. 
 
Table 1. Quintero staging system of TTTS based on ultrasonographic findings [13]. 
DVP= deepest vertical pocket. *Absent or reversed end-diastolic velocity. **Pulsatile 
flow. ***Reversed flow. 
 
2.3.1 Clinical manifestations 
As a result of hypovolemia, the donor is exposed to renal hypoperfusion, leading to 
oliguria and oligohydramnios. In its attempt to compensate for the volume depletion 
and hypotension, the donor responds with an increased production of renin [14]. This 
release results in an upregulation of angiotensin-II synthesis and an intrarenal 
vasoconstriction in the donor with an accentuation of the oligohydramnios. Meanwhile 
in the recipient, the hypervolemia results in atrial distension mediating a release of 
atrial natriuretic peptide, decreasing tubular reabsorption and thus worsening the 
Quintero stages Sonographic or Doppler findings 
 I Polyhydramnios, DVP ≥ 8 cm in recipient’s sac and 
oligohydramnios, DVP ≤ 2 cm in donor’s sac with visible 
bladder in donor 
II As in I but no visible bladder in donor 
III As in II and abnormal Doppler flow of umbilical artery*, 
umbilical vein** or ductus venosus *** 
IV As in III and hydrops of either twin 
V Fetal demise of one or both twins 
VVA 
AVA 
REC DON 
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polyhydramnios. Paradoxically, the upregulated renin production of the donor 
transferred through the AVA results in fetal hypertension of the recipient despite its 
own downregulation [14-16]. As a consequence of the hypertensive disorder, the 
recipient gradually develops myocardial hypertrophy primarily of the right ventricle, 
followed by atrioventricular regurgitations and a decreased diastolic ventricular filling 
[17], Figure 3. Renin-angiotensin (RAS) activators have been found to be produced in 
the kidney of the donor and in the placental territory of the recipient (Ref Galea P, 
Placenta 2008). 
 
Figure 3. Heart of a recipient fetus with right ventricular (RV) hypertrophy and 
tricuspid and mitral valve regurgitations (TR, MR).  
 
 Endothelin-1, another potent vasoconstrictor, has been found to occur in twice as high 
serum concentrations in recipients compared with their donors, and with the highest 
levels observed in recipients with severe fetal hydrops [18]. All vasoactive mediators 
transported across the anastomoses may contribute to the development of hypertension 
and cardiomyopathy in the recipient fetus [19]. In other studies of TTTS gestations, 
elevated levels of brain natriuretic peptide and cardiac Troponin-T have been reported 
in recipients, suggesting a myocardial damage and remodeling with possible long term 
effects on cardiac function [20, 21]. However, for early diagnosis of TTTS in the first 
trimester, there has been no data supporting high levels of these substances. 
2.3.2 Diagnostics  
Fetal ultrasonography 
As the chronic unbalanced volume shift makes the donor hypovolemic, oliguric, 
hypotensive and subsequently growth retarded, the recipient becomes hypervolemic, 
polyuric and hypertensive. With an aggravating oliguria, the urinary bladder of the 
donor will be invisible. The hemodynamic alterations of the twin fetuses are reflected 
in Doppler flow abnormalities of umbilical vessels. The end-diastolic flow of the 
umbilical artery of the donor becomes absent or reversed whereas a pulsatile Doppler 
signal of the umbilical vein in addition with a reversed flow in ductus venosus can be 
seen in the recipient, Figures 4 and 5. In advanced stages of TTTS, the fetuses might 
develop ascites or hydrops as an indication of severe cardiovascular compromise, 
Figure 6.  
TR 
TR 
MR 
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Figure 4. Pulse wave Doppler in umbilical vessels of a normal fetus (left) and a 
recipient fetus with systemic hypertension (right). Umbilical artery (UA) and vein 
(UV).  
 
 
Figure 5. Pulse wave Doppler in ductus venosus of a normal fetus (left) and of a 
recipient fetus with systemic hypertension (right). 
 
 
Figure 6. A recipient fetus with ascites (asc). UC= umbilical cord. 
 
For specific grading of cardiovascular severity, the CHOP scoring system has been 
suggested by Rychik et al [17]. The prognostic value of the scoring system has been 
questioned and considered too time consuming to be useful in a clinical setting [22]. As 
there is no non-invasive method to measure fetal systemic blood pressure, the 
ultrasonographer may identify indirect signs. Fetal hypertension is first observed as 
ventricular hypertrophy with atrioventricular regurgitation followed by a compromised 
UA 
UV 
UA 
UV 
asc 
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diastolic filling resulting in a prolongation of isovolumetric relaxation time (IVRT) and 
a monophasic atrioventricular inflow profile with short duration. Late signs of fetal 
hypertension includes systolic ventricular dysfunction [17, 21, 23, 24].  
 
Quantifiable changes in left and right ventricular wall thickness of recipients as well as 
an increased myocardial performance index (MPI) indicating impaired global 
ventricular function has been demonstrated in early stages of TTTS [25, 26]. The right 
ventricle of the recipient is earlier and more severely affected than the left, and can 
occasionally also develop right ventricular outflow obstruction (RVOTO) and 
pulmonary valve stenosis due to impaired flow owing to hypertrophy [27-30]. In 
contrast, the hypovolemic donor twin shows little cardiac pathology on fetal 
echocardiography but does manifest a slightly hyperdynamic heart and central 
hemodynamics similar to that seen in other kinds of placental dysfunction.  
 
While conventional Doppler assesses the velocity of blood flow by measuring high-
frequency, low-amplitude signals from blood cells, Doppler tissue imaging (DTI) uses 
Doppler shifts of the myocardium to quantify the higher amplitude and lower velocity 
signals of tissue motion (displacement and velocity) [31]. However, the angle 
dependency of the DTI technique limits the usefulness. Since speckle tracking 
echocardiography, also named velocity vector imaging (VVI), is angle independent, it 
may be used as a supplement for assessment of systolic function [32]. Lately, several 
centers have reported VVI assessments of TTTS fetuses [33-35]. Recipient fetuses 
demonstrated early impairment of ventricular strain, whereas donors exhibited higher 
strain values indicating a hyperdynamic myocardium [34, 36, 37]. Ventricular strain 
measured with speckle tracking has so far not been studied in TTTS children after birth.  
 
Despite a few reports of prognostic variables in TTTS, such as the presence of AAA 
[38, 39], at present there is no known fetal or maternal variable that identifies patients 
at risk for progression. Different European centers have established guidelines for 
surveillance and treatment of TTTS, but such guidelines are still lacking in Sweden. 
 
Chronic TTTS differs from other forms of twin transfusions by the discordance of 
amniotic fluid between twins, Table 1. In the twin-anemia-polycythemia-sequence 
(TAPS), few and very small AVA at the chorionic plate results in a large inter-twin 
hemoglobin difference with one anemic and one polycythemic twin fetus. TAPS should 
be suspected if there are Doppler findings of abnormal and divergent peak systolic 
velocities of middle cerebral arteries in MC twins but no oligo/polyhydramnios [40, 
41]. Due to the inter twin transfusions, there is a difference in reticulocyte count at 
birth. A third form, the acute twin-twin transfusion, occurs right before or at delivery 
and results in one anemic and one polycythemic twin, without discordant reticulocyte 
count.  
2.3.3 Fetal intervention and treatment 
To reduce the risk for premature rupture of membranes and preterm labor due to the 
polyhydramnios distending the uterus, different treatment strategies have been 
developed. Selective feticide by umbilical cord occlusion (trying to save at least one 
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twin), septostomy, amnioreductions alone or in combination with indomethacin, have 
all been used to prevent adverse outcome [42-44]. Serial amnioreductions was most 
frequently used until the late 1980s, when De Lia pioneered the use of selective 
fetoscopic laser occlusive coagulation (FLOC) [45]. FLOC is executed under local 
anesthetics with an ultrasound guided fetoscope inserted into the amnion cavity of the 
recipient, whereas the vessels crossing the vascular equator are identified and 
coagulated by pulsed laser of 50-60 W effect. The procedure is terminated with amnio-
drainage [46, 47]. Complications reported with FLOC are e.g. placental abruption, 
rupture of membranes and fetal demise.   
A meta-analysis of laser treatment of TTTS reported an 80 % chance of delivering at 
least one liveborn twin [48]. With a high incidence of neonatal deaths, primarily due to 
very preterm birth, reporting the rate of overall survival passed the neonatal period is 
recommended and more adequate than reporting liveborn rates. Currently, an overall 
survival rate of 50-70 % can be expected [49]. So far, there are only two randomized 
controlled trials (RCT) comparing serial amnioreductions with FLOC and both were 
terminated earlier than planned due to interim analyses showing significantly higher 
survival rate after FLOC. The overall survival after FLOC at 6 months of age was 56 % 
in the Eurofetus study [43] and 45 % at 30 days in the NICHD trial [50]. With current 
level I evidence for FLOC treatment vs. amnioreduction for TTTS ≥ stage II, laser 
treatment of stage I is still questioned as there may be a chance of either spontaneous 
regress or a non-progress.  
Centers of fetal medicine treating TTTS are still challenged to improve rates of fetal 
survival, but there are also reasons for the perinatal team to consider best ways to 
increase neonatal survival in donors and recipients. Outcome on survival, neonatal 
disease and neurodevelopment after establishing a new therapeutic method is 
important, and Swedish data have been missing. 
2.3.4 Blood pressure and vascular function after TTTS 
Based on fetal hypertension (recipient) and upregulation of renin synthesis (donor), BP 
monitoring has been suggested in TTTS neonates. Neonatal BP has in smaller series 
been reported to be higher in recipients than in donors [51-54]. Only a few studies have 
focused on long term vascular consequences of TTTS. Pulse wave velocity, reflecting 
vascular stiffness, was found to be increased in the brachial artery of donors compared 
with recipients, a finding suggested to be an effect of fetal arterial remodeling and a 
risk factor for later hypertension [55, 56]. Furthermore, a meta-analysis of pulse wave 
velocity studies has confirmed that it is predictive for total cardiovascular events [57]. 
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3 AIMS 
The overall aim of this thesis was to study outcome in twin pregnancies complicated 
with TTTS or fetal growth retardation, in order to provide pregnant women and 
obstetricians with up-to-date information for antenatal counseling, to improve perinatal 
care and to define the need for long-term cardiovascular follow-up.  
 
The specific objectives were:  
 To evaluate whether discordant fetal growth contributes to later differences in 
blood pressure and vascular functions in twins (Paper I). 
 To perform a ten year follow-up of cardiac structure and function in twins 
treated with amnioreductions due to TTTS (Paper II). 
 To determine infant survival and neonatal outcome after fetoscopic laser 
coagulation therapy of TTTS in Sweden (Paper III). 
 To study cardiac structure and function in childhood after TTTS treated with 
fetoscopic laser coagulation (Paper IV).
10 
  
 
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4 MATERIAL AND METHODS 
4.1 SETTINGS AND STUDY COHORTS 
All twins included in Papers I- II were born within the Stockholm region and 
assessments were conducted in clinical settings at Karolinska University Hospital in 
Solna, Danderyd or Huddinge. All cardiac examinations of Paper IV were conducted in 
the pediatric cardiology unit of Sachs’ Children and Youth Hospital. Data of the laser 
treated women and their offspring of Paper III, were collected in a hospital-based 
registrer at the Centre for Fetal Medicine at Karolinska in Huddinge. 
 
Table 2. Number of twin subjects (fetuses or children) studied in Papers I-IV. 
Paper I II III IV 
MZ –with TTTS 
  no laser treatment 
  laser treatment 
 
18 
 
22* 
 
 
142 
 
 
38 
MZ – no TTTS 26    
DZ 18    
Singleton controls    19 
Total 62 22* 142 57 
* 18/22 subjects same as in Paper I 
4.1.1 Paper I 
This observational study of intrauterine growth retardation and later blood pressure and 
vascular function, consisted of twins recruited from two different birth cohorts of the 
Stockholm region. From log-books of all births (n > 60,000) at Karolinska and 
Danderyd in Stockholm during 1991–1997 we found 35 live born same-sexed twin 
pairs in whom one was appropriate for gestational age (AGA; birth weight = mean ± 2 
SD) and the other small for gestational age (SGA; birth weight more than 2 SD below 
the mean) according to Swedish reference data [58]. Very preterm delivery (gestational 
age: < 32 weeks) was excluded. Four families were lost to follow-up, the remaining 31 
families were invited and 22 accepted to participate in the study. Another twin cohort, 
consisting of all consecutive and prospectively diagnosed TTTS pairs in which both 
twins survived and were born in Stockholm during 1994–1997, was also included (n = 
9 pairs). The TTTS pregnancies were diagnosed at Södersjukhuset in Stockholm, where 
six of the women underwent treatment with amnioreductions alone or in combination 
with indomethacin. Altogether 62 twins (34 girls, 28 boys) were studied at an age of 7.8 
(4.6–11.8) years and divided into three groups: (i) monozygous without TTTS (MZ 
without TTTS), (ii) monozygous with TTTS (MZ with TTTS) and (iii) same-sexed 
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dizygous (DZ) twins. Chorionicity was established on the basis of histology of the 
separating membrane. In cases of dichorionic placentas (n =12) or unknown 
chorionicity (n =2), the determination of monozygosity relied on parental reporting of 
mistaken identity.  
4.1.2 Paper II 
The subjects of this study were recruited from the same TTTS cohort from 
Södersjukhuset as assessed in Paper I, but with the inclusion of another two pairs for a 
total of eleven twin-pairs, with mean age 9.6 (7.2-11.8) years. Besides treatment with 
one or serial amnioreductions, some were also treated with indomethacin. Because of 
the risk for closure of the ductus arteriosus before birth, all fetuses treated with 
indomethacin were monitored with echocardiography every 1 to 2 weeks. During 
gestation, three recipient fetuses gradually developed cardiomyopathy illustrated by 
cardiomegaly, regurgitant atrioventricular valves, ventricular hypertrophy and reduced 
systolic function. Abnormal findings in the right ventricle preceded and were more 
severe than those observed in the left ventricle. In two of these recipient fetuses, there 
were also signs of right ventricular outflow tract obstruction (RVOTO). Distribution of 
Quintero stages in the group was: two of stage I, eight of stage II, and one of stage IV.  
4.1.3 Paper III 
Data was prospectively collected from all pregnancies treated with fetoscopic laser 
occlusive coagulation between Oct 2001 and July 2010, at the Center for Fetal 
Medicine at Karolinska University Hospital in Huddinge. There were 123 pregnant 
women referred to the center for fetal medicine at Karolinska University Hospital in 
Huddinge for consideration of fetoscopic laser coagulation treatment due to suspected 
TTTS. Among the referrals there were two triplet pregnancies. In 14 of the referrals, 
TTTS diagnosis could not be confirmed. All confirmed TTTS pregnancies were graded 
using the Quintero staging system [13]. Laser treatment was considered indicated if 
Quintero stage was II-IV and gestational duration was ≤ 26 weeks, n=71; stage II = 34, 
III = 31 and IV = 6. In addition, two women with Quintero stage I were treated due to 
pronounced maternal discomfort from excessive polyhydramnios. Overall, 73 pregnant 
women with confirmed TTTS were treated with FLOC. Twenty-six treated patients 
were referred from hospitals within the region (37 %) and 42 (59 %) from other regions 
of Sweden. Three women (4 %) came from other Nordic countries (Norway, n=2, 
Finland, n=1). During the study period, TTTS-patients living in the most southern part 
of Sweden, and in need of FLOC, were referred to Denmark or Germany. 
 
The median gestational age at FLOC was 21 (range 17-26) weeks. Three women had 
been treated with amnioreductions before FLOC and eight underwent amnioreductions 
after FLOC. Due to an insufficient result of the first FLOC, two women were treated 
twice. There was no maternal mortality related to the intervention. 
4.1.4 Paper IV 
This observational cohort study of cardiovascular function of TTTS twin pairs 
surviving fetoscopic laser occlusion was conducted from Dec 2011 until Jan 2013. 
Children were recruited from the laser treated cohort studied in Paper III. Only twins 
with survival of both twins were included, to be able to make within-pair comparisons. 
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Of twenty-one surviving twin-pairs, one family did not respond to mail and another 
declined to participate. Nineteen twin-pairs were examined by the same experienced 
technician at the pediatric cardiology unit at Sachs’ Children and Youth Hospital. In 
addition, a gender- and age matched control group of nineteen healthy singletons was 
examined.   
4.2 CARDIOVASCULAR MEASUREMENTS 
4.2.1 Blood pressure determinations (Papers I, II and IV) 
BP was recorded after 30-45 min of rest. An automated oscillometric 
sphygmomanometer was used with an appropriately sized cuff around the right upper 
arm. The mean value of three consecutive determinations was regarded as the subject’s 
BP. The coefficient of variation (CV) was calculated to 9.5 % for systolic (SBP) and 
9.9 % for diastolic blood pressure (DBP), i.e. the same as in other pediatric studies [59, 
60]. 
 
4.2.2 Arterial dimensions and stiffness (Paper I) 
To obtain data on the mechanical properties of the abdominal aorta (AA) and the left 
common carotid artery (CCA) we used ultrasonography. A computer-generated pair of 
electronic echo-trackers (DiamoveTM, Teltec AB, Lund, Sweden) was used to measure 
the end-diastolic diameter (Dd; mm), pulse amplitude of the diameter (ΔD; mm) and 
relative strain (ratio: ΔD/Dd, %), Figure 7. These diameter data and those of 
simultaneously measured BPs were computed to yield the stiffness index (β) using the 
equation: β = ln(SBP/DBP) x Dd /ΔD [61]. The mean value of three recordings, each 
consisting of about 6–10 consecutive heart cycles, was taken as the subject’s reading. 
More on this technique has been described by Hu et al [62]. 
 
 
Figure 7. Ultrasonic echo-tracking system measuring arterial end-diastolic diameter and 
pulse amplitude. 
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4.2.3 Endothelial function (Paper I) 
Measurements of changes in perfusion during vascular drug provocations of the skin 
have been used to determine endothelial function. In this study we used a laser Doppler 
instrument and a micropharmacology system (Perimed AB, Kista, Sweden). The laser 
Doppler signal is proportional to the number and velocity of moving blood cells 
through the illuminated superficial skin microvessels and expressed in perfusion units 
(PU) of output voltage (1 PU = 10 mV).  
 
Endothelium-dependent vasodilation:  
To study endothelium-dependent vasodilation, perfusion was recorded after transfer of 
acetylcholine (ACh) across the skin by iontophoresis (anodal current of 0.1 mA for 20 s 
repeated six times at 60 s intervals), Figure 8. 
  
Endothelium-independent vasodilation:  
To study endothelium-independent vasodilation, the effect of an exogenous nitric oxide 
donor (1% nitroglycerine) was tested on the contralateral hand. More details concerning 
these methods have been described by Martin et al [63]. 
 
 
Figure 8. Skin perfusion response to transdermal administration of acetylcholine with 
iontophoresis. 
 
4.2.4 Echocardiography (Papers II and IV) 
All echocardiographic assessments of Paper II were made with an Acuson Sequoia 
ultrasound system (Siemens Corp., Mountain View, CA, USA).  
In Paper IV, echocardiographic examinations were performed using an Acuson SC2000 
(Siemens Medical Solutions, Mountain View, CA, USA), by the same experienced 
technician at the Paediatric Cardiology Unit, Sachs’ Children and Youth Hospital. 
Analyses were made off-line on Syngo Dynamics WS and SC2000 WP (Siemens 
Medical Solutions, Mountain View, CA, USA). All assessments were performed 
according to the standards of the European and American Societies of 
Echocardiography [35, 64, 65]. 
 
2D and M-mode measurements (Papers II and IV) 
M-mode images from a parasternal long axis view were used to measure 
interventricular septum (IVS), left ventricular posterior wall (LVPW) and right 
ventricular anterior wall (RVAW) thickness in the end of diastole. Left ventricular end-
diastolic and systolic diameters (LVED, LVES) were obtained from the same images 
and used to calculate shortening fraction (SF). Two dimensional (2D) images were 
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documented as 3 cine-loops, each covering two heart cycles, with a frame rate of 70-
100 frames/sec. A parasternal short axis view was used for assessing 2D diameter of 
right ventricular outflow tract (RVOT), and a parasternal long axis view for measuring 
diameter of left ventricular outflow tract (LVOT).  
 
For additional assessments (Paper IV), we used 2D records from an apical four-
chamber view to measure left and right ventricular longitudinal dimensions (LVmaj, 
RVmaj) and the M-mode technique was used to estimate the mitral and tricuspid 
annular plane systolic excursion of the left (MAPSE) and right (TAPSE) ventricular 
free walls. TAPSE/RVmaj and MAPSE/LVmaj ratios were calculated to obtain the 
longitudinal shortening fractions of each ventricle (RV long SF, LV long SF). Each 
measurement was made at least three times and averaged. For conversion to z-score, we 
used reference values from Daubeney (Paper II) [66] and Pettersen (Paper IV) [67]. Z-
score is a statistical measurement of a score's relationship to the mean in a group of 
scores. Accordingly, the mean was defined from these references.  
 
Blood flow and tissue Doppler (Papers II and IV): 
Pulsed wave (PW) Doppler flow velocity recordings were obtained from LVOT and 
RVOT for calculations of their velocity time integrals (RVOT VTI, LVOT VTI) as 
semi-quantitative estimates of stroke volumes. Recordings from pulmonary (PV) and 
aortic valves (AoV) were used to obtain peak velocity (Vmax) as an estimate of 
outflow patency. Continuous wave Doppler was used to measure the peak velocity of a 
frequently present clinically insignificant tricuspid regurgitation jet, as an indirect 
assessment of right ventricular systolic pressure.  
Diastolic function was investigated using mitral (MV) and tricuspid valve (TV) 
Doppler flow velocity recordings, where early (E) and late atrial (A) filling peak 
velocities were measured and E/A ratios calculated, Figure 9. 
 
Figure 9. Doppler assessed early (E) and late, atrial (A) right ventricular inflow in 8 
year old former donor (left) and recipient (right). Note the tricuspid regurgitation (TR).  
 
Values were compared with reference data from Eidem et al [68]. The myocardial 
performance index (MPI), assessing combined systolic and diastolic function of the left 
ventricle, was obtained by extracting the isovolumetric contraction (IVCT), 
isovolumetric relaxation (IVRT) and ejection (ET) time intervals from recordings of 
mitral valve inflow and left ventricular outflow profiles, and thereafter calculated using 
the formula; MPI = (IVCT+IVRT)/ET. Pulsed wave Doppler tissue imaging (DTI) was 
TR 
TR 
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used to record myocardial velocities in the basal free walls of the left and right 
ventricle. From these recordings, peak e’ and a’ velocities and time intervals were 
measured and e’/a’ ratio and mpi were calculated with the same approach as for flow 
Doppler recordings. These records were furthermore used to measure the isovolumetric 
relaxation and contraction times (ivrt, ivct).  
 
Speckle tracking echocardiography (velocity vector imaging=VVI) (Paper IV): 
VVI can be used to study cardiac mechanics and quantify global and regional cardiac 
function through assessments of longitudinal and circumferential deformation where 
strain (%) describes myocardial deformation and is positive or negative depending on 
lengthening or shortening and strain rate (sec-1) is the rate of change in strain [35]. An 
apical four-chamber view was used to record 2D cine-loops with a frame rate of at least 
70-90 frames/sec for later off-line analysis using SC2000 WP, VVI version 3.0 
(Siemens Medical Solutions, Mountain View, CA, USA).  
To study longitudinal deformation of the ventricles, the endocardial borders were 
manually traced from the free wall edge of the atrioventricular valve annulus, extending 
to the apex, and continuing back to the septal edge of the atrioventricular valve annulus, 
for left and right ventricle separately, Figure 10. From data presented by the software, 
we selected the global average from all segments of the ventricular walls during peak 
systole as estimates of ventricular deformation; namely longitudinal peak systolic 
global strain and strain rate. The intraobserver variability when calculating global strain 
was 11 % for the right ventricle and 14 % for the left ventricle.  
 
 
 
 
 
 
Figure 10. Speckle tracking of endocardial borders to obtain longitudinal systolic strain 
of right and left ventricles. 
3D volumes: (Paper IV) 
Single beat 3D echocardiography was used to obtain end-diastolic and systolic volumes 
of right (RV EDV, RV ESV) and left ventricles (LV EDV, LV ESV), using a 4Z1c 
transducer from an apical four-chamber view. For each ventricle, the stroke volume 
(SV) was calculated by subtracting ESV from EDV.  
 
TR 
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4.3 MATERNAL AND NEONATAL DATA COLLECTION (PAPER 
III) 
Data on all MC pregnancies referred to the center for fetal medicine at Karolinska 
University Hospital at Huddinge, was prospectively collected in a hospital-based 
register. For this purpose, records from maternal, fetal, neonatal and pediatric 
departments of local clinics were required. Survival up to one year of age was selected 
as the primary outcome. Secondary outcomes included the following neonatal data and 
diagnoses; Apgar score < 7 at 5 minutes, birth weight and z-score for birth weight (BW 
z-score), birth length, birth head circumference, respiratory distress syndrome (RDS), 
need for any mechanical ventilation, treatment for patent ductus arteriosus (PDA), 
culture-proven septicemia, a diagnosis of structural cardiac disease, renal failure, severe 
brain injury (defined as intraventricular hemorrhage ≥grade 3 and/or cystic 
periventricular leukomalacia), pulmonary hypertension, bronchopulmonary dysplasia 
(BPD, defined as need of supplemental oxygen at 36 weeks of postmenstrual age) and 
severe retinopathy of prematurity (ROP ≥ grade 3).  
 
4.4 STATISTICAL ANALYSES 
4.4.1 Paper I: 
To study differences between groups, chi-square and ANOVA were used. Mean 
within-pair differences (95 % confidence interval) were calculated (= value in the 
lighter twin at birth - value in the heavier twin at birth) and two-sided paired t-test was 
used for co-twin comparisons of continuous variables. Regression analyses were used 
to evaluate contributions to within-pair differences from the following risk factors or 
confounders: group (MZ-no TTTS, MZ-TTTS and DZ), preeclampsia, use of antenatal 
steroids, gender, current age, weight and height.  
4.4.2 Paper II: 
Wilcoxon test for matched pairs was used to compare the recipient with the donor 
within each pair of twins, and the t-test for single means was used to test if the 
standardized measurements of the valve areas (z-scores) deviated from reference 
values.  
4.4.3 Paper III: 
To study differences between groups, Chi-square test was used for categorical variables 
or proportions, and Student’s t-test or Mann-Whitney U-test was used for continuous 
variables. Comparing donor and recipient twins, chi-square, paired t-test or Wilcoxon’s 
signed ranks test was used according to Mc Nemar [69]. Linear regression was used to 
test for associations between maternal and obstetric characteristics and infant survival.  
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4.4.4 Paper IV: 
For comparisons between donors, recipients and controls, we used matched paired t-
tests. Variables with observed differences between groups were also analyzed using 
linear regression to evaluate the possible contribution of gestational age at birth or 
BSA, when appropriate. 
 
For all four studies, a p-value < 0.05 was considered significant. 
 
 
 4.5 ETHICAL APPROVALS 
All families of the cardiovascular observation studies provided written informed 
consent (Papers I, II and IV). The women treated with fetoscopic laser coagulation 
were contacted by regular mail a few weeks after treatment, and asked for a written 
informed consent for data acquisition of medical records including data on offspring 
(Paper III). All study protocols were approved by Regional Ethics Review Board in 
Stockholm with identification numbers: 00-277, 412-00, 2010/2010-31/4. 
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5 RESULTS 
5.1 BLOOD PRESSURE 
5.1.1 Paper I  
The overall systolic blood pressure (SBP) was 101 (1.3) and diastolic BP (DBP) 59 
(0.7) mmHg. After taking age, gender and height into account, 8/62 twin subjects had a 
SBP above the 90th centile, according to normative data from North American children 
[60]. Among those with high SBP, four were MZ-TTTS subjects (two donors and two 
recipients), three were MZ twins without TTTS and small at birth and one was a DZ 
twin with normal birth weight. The gestational age, current age- and gender distribution 
were similar in those with and those without a high SBP. The SBP and DBP in children 
with a history of maternal preeclampsia or antenatal steroid therapy did not differ 
significantly from those without such a history (p-values 0.67-0.83).Within all pairs 
there was a trend towards higher SBP (mean +2.6 mmHg, p =0.08) and pulse pressure 
(mean +3.0 mmHg, p=0.09) in the twin with lower birth weight, compared with the 
heavier twin. The differences were more marked among MZ twins without TTTS; SBP 
was +5.2 (CI +0.1 – +10, p=0.04) higher in the lighter than the heavier MZ twin 
sibling. Within-pair SBP differences did not show any significant relation to the degree 
of birth weight discordancy (regression coefficient: +4.8 mmHg/kg lower birth weight 
in the lighter twin, p = 0.39). Moreover, we found no significant within-pair differences 
in DBP or heart rate, Table 2. Multivariate regression analyses indicated that 
contributors to the within-pair difference in SBP were pregnancy history of 
preeclampsia, antenatal steroid treatment and monozygosity. Age, gender, current 
weight and height differences did not significantly affect SBP discordance.  
 
Table 2. Within-pair blood pressure differences in 8-year-old twins with discordant 
birth weights. 
 
 
MZ- no TTTS 
n=13 
MZ-TTTS 
n=9 
DZ 
n=9 
SBP, mmHg +5.2(+0.1;+10) -0.1(-3.2;+3.1) +1.6(-6.3;+9.4) 
DBP, mmHg +1.4(-2.0;+4.8) -1.4(-7.4;+4.5) +1.1(-3.5;+5.7) 
Heart rate, bpm -3.3(-7.7;+1.0) -1.3(-6.1;+3.5) +4.3(-1.2;+9.8) 
MZ- no TTTS = monozygous twins without TTTS, MZ-TTTS = monozygous twins 
with TTTS, DZ = dizygous twins, SBP=systolic blood pressure, DBP=diastolic blood 
pressure, bpm = beats per minute. Difference: value in the lighter – value in the 
heavier twin at birth/ value in the heavier twin at birth x 100. Mean (lower; upper 
limits for 95 % confidence interval) values, bold indicates p < 0.05. 
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5.1.2 Paper II   
The mean (SD) of SBP; DBP was 100 (±8.0); 56.6 (±6.6) in the donor group and 101 
(±10.9); 58.4 (±8.5) in the recipient group, the difference between the groups was not 
significant.  
5.1.3 Paper IV 
The mean (SD) of SBP; DBP was 91.1 (±6.7); 56.8 (±4.6) in the donor group, 90.0 
(±12.3); 55.4(8.4) in recipient group and 56.5(±6.9) in control group, the differences 
between the groups were not significant. 
 
5.2 ENDOTHELIAL FUNCTION 
5.2.1 Paper I 
The overall mean basal skin perfusion was 11 (1.5) perfusion units (PU) and the 
maximum increase in perfusion induced by the endothelium-dependent vasodilator 
ACh was 110 (5.7) PU. Basal skin perfusion did not differ between the lighter and 
heavier twin. In the MZ group, the lighter twin had a 40 PU lower maximum response 
to ACh than the heavier twin (p < 0.05), Figure 11. In the MZ-TTTS and DZ groups, 
the within-pair differences in responses to ACh were not significant. Preeclampsia 
reduced the within-pair difference in maximum skin perfusion response to ACh (6.2 
PU, n.s.). In contrast, in pregnancies with discordant twin growth but without 
preeclampsia the ACh skin perfusion response was 34 PU lower in the twin with lower 
birth weight (p < 0.05). The mean basal skin perfusion before testing endothelium-
independent vasodilation was 11 (1.0) PU. The maximum increase in skin perfusion 
after topical application of nitroglycerin was 35 (2.4) PU. The mean difference in 
response to nitroglycerin between lighter and heavier twins was statistically significant 
among girls (- 13 PU, p < 0.05), but not among boys (- 4.5, n.s). 
Figure 11. Intra-pair comparisons in vasodilation response to acetylcholine between 
heavier (■) and lighter (▲) monozygous twin.  
   21 
5.3 ARTERIAL DIMENSIONS AND ELASTICITY 
5.3.1 Paper I 
Among MZ and DZ twins, no intra-pair differences were detected in CCA dimensions, 
changes in pulsatile diameter or stiffness. In the MZ-TTTS group, the donor twin had a 
CCA diameter that was -0.3 (95 % CI: -0.6 - 0) mm or 5 % narrower than that of the 
recipient twin. The donor also showed +3 (95 % CI: 1-5) % higher carotid strain than 
the recipient. The AA strain was higher in the recipient than in the donor, however 
there was no significant difference in stiffness index or end-diastolic diameter between 
twins of any group. The results did not differ significantly from reference data for 
healthy school-aged singletons with normal birth weights [63]. By calculating the 
arterial stiffness index, we adjusted for differences in strain due to those in BP.  
5.4 ECHOCARDIOGRAPHIC MEASUREMENTS 
5.4.1 Cardiac dimensions 
Paper II: 
We found no significant differences between donors and recipients regarding diameters 
of ventricular cavities, walls and outflows, coronary arteries or AV-valves. Three 
donors and three recipients had tricuspid valve areas below -2 SD according to 
reference data reported by Daubeney et al [66]. Among those recipients, two had 
myocardial hypertrophy during fetal life. 
 
Paper IV: 
LVED and thickness of septum and free ventricular walls (IVS, LVPW, RVAW) did 
not differ between groups after adjusting for body surface area (BSA) [67]. The 
unadjusted longitudinal RVmaj and LVmaj in recipients were similar to those in donors 
but smaller than in controls. Similar observations were made for measurements of the 
ventricular outflow tracts (RVOT, LVOT). With the exception of one former donor 
with a mild pulmonary valve stenosis diagnosed at birth, no cardiac malformations 
were diagnosed. Unadjusted left ventricular EDV and SV of both ventricles measured 
with 3D were reduced in donors compared with recipients and controls. 
5.4.2 Systolic and diastolic function 
Paper II: 
Doppler flow variables as well as M-mode derived SF did not demonstrate any 
differences in systolic function between twins. Recipients had lower peak velocities of 
early diastolic filling (E-wave) of left and right ventricle and a reduced E/A ratio 
compared with donors and measured with conventional Doppler, Figure 12. Similar 
findings were observed with DTI technique. 
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Figure 12. Diastolic early (E) and late (A) filling blood flow velocities through the 
tricuspid (TV) and mitral (MV) valves (to the left) as well as their E/A ratios (to the 
right). Lines connect the observations made in the donor (left) with the recipient (right) 
within each pair of twins. Symbols with error bars represent the mean ± standard 
deviation. Filled symbols with error bars denote the former donors and unfilled 
symbols with error bars denote the former recipients. 
Paper IV: 
The only observed differences between donors and recipients were related to diastolic 
ventricular filling. Recipients had a lower E/A ratio in the mitral valve compared with 
donors, whereas in comparison with controls there was no statistical difference. There 
were no significant differences in E/A ratio of the tricuspid valve between groups, but 
recipients had a tissue velocity-derived e’/a’ ratio that was lower than the donors’, but 
not significantly different from the controls’, Figure 13. Linear regression analysis did 
not show any contribution of gestational age at birth to these differences. 
 
Longitudinal global peak systolic strain of left ventricle did not differ between donors 
and recipients, but donors had a slightly lower left ventricular strain than controls. 
There was no difference in strain rate between groups, Table 3.  
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Figure 13. Ratio of diastolic early (E) and late (A) filling blood flow velocities in the 
mitral (MV) and tricuspid (TV) valves. Solid lines connect observations made within 
each pair of twins. Symbols with error bars represent the mean ± 1 standard deviation. 
Broken lines are upper and lower 95 % reference limits constructed from data 
published by Eidem [68] (Paper IV). 
 
 
Table 3. Longitudinal myocardial deformation measured with velocity vector imaging 
(VVI) of global strain and strain rate in donor, recipient and control children. Values 
are presented as mean (1 SD). 
 
donors, 
n=19 
recipients, 
n=19 
don vs. 
rec p-
value 
controls, 
n=19 
don vs. 
contr p-
value 
rec vs. 
contr p-
value 
LV peak systolic 
global strain, % 
-17.6(4.0) -19.5(4.9) 0.18 -20.8(3.5) 0.03 0.39 
LV systolic global 
strain rate, s
-1
 
-1.3(0.3) -1.4(0.4) 0.30 -1.4(0.3) 0.24 0.93 
RV peak systolic 
global strain, % 
-21.8(5.2) -20.3(6.6) 0.36 -24.6(4.0) 0.12 0.05 
RV systolic global 
strain rate, s
-1
 
-1.9(0.4) -1.8(0.7) 0.57 -1.9(0.5) 0.82 0.57 
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5.5 OUTCOMES AFTER LASER TREATMENT 
5.5.1 Maternal and obstetric characteristics 
In the studied laser treated cohort, preterm birth was twice as common and extremely 
preterm birth ten times as common as among Swedish twin births in general, Table 4. 
  
Table 4. Maternal and obstetric characteristics in laser treated TTTS pregnancies 
compared with all Swedish multiple pregnancies. Data from Swedish Medical Birth 
Register 2009 [70]. Values are medians or proportions. 
 
Laser treated cohort 
n=71 
All Swedish duplex 
n=1,544 
Age, years 31.3  32.0 
Smoking, % 7.0 6.4 
Assisted fertilization, % 16 22 
Nulliparous, % 38 44 
BMI, kg/m
2 
23 24 
Caesarean section, % 66 54 
Preterm  
(GA < 37 w), % 89 44 
Very preterm born  
(GA < 32 w), % 
53 10 
Extremely preterm 
 (GA < 28 w), % 
40 3 
 
5.5.2 Survival after laser treatment 
In 53/71 (75 %) laser treated TTTS cases, at least one twin was liveborn and in 43/71 
(60 %) at least one twin survived infancy. Fetal survival did not differ between donors 
(41/71 [58 %]) and recipients (46/71 [65 %], p=0.36). Among liveborn infants, survival 
was 29/41 (71%) in donors and 37/46 (80%) in recipients (p=0.10), Figure 14. Only 
one live born infant delivered before 25 gestational weeks (n=8) was alive at one year 
of age, Table 5. If delivery occurred after 28 gestational weeks, 88 % of donors and 96 
% of recipients were still alive after one year. In pregnancies ending with two liveborn 
infants, both survived to 1 year in 21/34 (62 %) of pregnancies. The proportion of 
liveborn infants did not differ between Quintero stages I-II (61 %) and III-IV (61 %). In 
addition, infant survival did not correlate to gestational age at FLOC.  
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Figure 14. Fetal and infant survival in TTTS donors and recipients after treatment with 
fetoscopic laser occlusive coagulation therapy (FLOC).   
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Table 5. Infant survival in 86 liveborn TTTS twins in relation to gestational age at birth 
(weeks
+days
). Values are total numbers (donors/recipients). 
 Extremely preterm Very 
preterm 
Moderately 
preterm 
Term 
Gestational age at birth, w 23-23
+6
 24-24
+6
 25-25
+6
 26-26
+6
 27-27
+6
 28-31
+6
 32-36
+6
 >37 
Liveborn 3(1/2) 5(2/3) 8(4/4) 13(6/7) 8(3/5) 11(6/5) 32(15/17) 7(4/3) 
Early neonatal death 
<24 h 
24 h-7d 
 
0/1 
1/0 
 
2/2 
0/1 
 
2/1 
1/1 
 
1/1 
 
 
 
 
1/1 
1/0 
  
Late neonatal death                                   
8-27 d 
  
1/0 
 
1/0 
    
Post neonatal death 
28 d -1 year 
     
0/1 
  
1/0 
 
Alive at 1 year 1(0/1) 
 
0(0/0) 
 
2(0/2) 
 
10(4/6) 
 
7(3/4) 
 
8(4/4) 
 
31(14/17) 
 
7(4/3) 
 
 
5.5.3 Neonatal anthropometry and disease 
As expected, donors had a significantly lower weight, length and head circumference at 
birth than their recipient twins (p < 0.01 for all comparisons). Although neonatal 
morbidity was found to be high, we did not find any significant differences in major 
neonatal morbidities between donors and recipients, Table 6.  
The rate of treatment with mechanical ventilation during neonatal stay was 46 %. The 
need of mechanical ventilation in relation to gestational age is described in Table 7. 
Persistent pulmonary hypertension of the newborn (PPHN) was reported in 11 % of 
recipients, but in none of the donors. Fetal myocardial hypertrophy was detected with 
ultrasound in twenty recipients, mostly presented as atrioventricular valve regurgitation 
and/or biventricular hypertrophy. Two of the donor fetuses were described as having 
signs of cardiac dysfunction, one of those also showing a valvular pulmonary stenosis. 
In the recipient group, there were two reported cases of obstructions of right ventricular 
outflow tract. At neonatal follow-up, one of these was diagnosed with a mild valvular 
pulmonary stenosis and the other with bilateral stenosis of the pulmonary branches. 
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Table 6. Neonatal morbidity and anthropometry in liveborn monochorionic twins 
treated with fetoscopic laser occlusive coagulation for twin-to-twin transfusion 
syndrome (TTTS). Donors and recipients reported separately. Values are numbers (%) 
or median (range). Z-score for BW according to Niklasson et al [71]. 
 Donors, n=41 Recipients, n=46 
GA
1
 at birth, weeks 30.8 (23.8-38.1) 29.0 (23.0-40.6) 
BW
2
, g 1,230 (266-3,591) 1,380 (400-3945) 
BW z-score
 
-2.18 (-5.32-0.81) -0.90 (-3.19-7.25) 
RDS
3
 23 (56 %) 24 (52 %) 
Mechanical ventilation 15 (36 %) 25 (54 %) 
Culture proven septicemia 6 (15 %) 12 (26 %) 
IVH ≥ grade 3/cPVL4 6 (15 %) 5 (11 %) 
PDA
5
 treated
 
4 (10 %) 5 (11 %) 
PPHN
6 
0 5 (11 %) 
Renal failure 5 (12 %) 4 (8.7 %) 
BPD
7 
at 36 w
 
4 (9.8 %) 5 (11 %) 
ROP
8   ≥ grade 3 2 (4.9 %) 4 (8.7 %) 
1
GA=Gestational age; 
2
BW=birth weight; 
3
RDS=respiratory distress syndrome;
 
4
IVH/cPVL=intraventricular hemorrhage or cystic periventricular leucomalacia;
 
5
PDA=patent ductus arteriosus; 
6
PPHN= persistent pulmonary hypertension of the 
newborn; 
7
BPD=bronchopulmonary dysplasia; 
8
ROP=retinopathy of prematurity 
 
Table 7. Numbers of liveborn TTTS twins treated with mechanical ventilation (MV) 
during the neonatal period.  
Gestational age at birth, 
weeks
+days Donors Recipients 
 
MV No MV MV No MV 
< 28
+0
 11 2 18 1 
28-31
+6 
2 4 3 2 
32-36
+6
 2 12 4 13 
≥ 37+0 0 4 0 3 
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6 DISCUSSION 
6.1 FINDINGS AND IMPLICATIONS 
The main findings of the thesis were that: 
 
1. Severe fetal growth retardation contributes to higher blood pressure, arterial 
narrowing and endothelial dysfunction in monozygous twins in childhood. 
2. Survival after fetoscopic laser treatment is poor if delivery occurs extremely 
preterm. No donor born before 26 gestational weeks survived infancy. 
3. Neonatal mortality and morbidity after laser treatment does not differ 
significantly between donors and recipients, except for temporary pulmonary 
hypertension and need for mechanical ventilation, which is more common 
among recipients. 
4. The risk for neonatal respiratory disease needing mechanical ventilation is 
increased in preterm TTTS twins compared with singletons of corresponding 
gestational age. 
5. Recipients showed a reduction in diastolic function at follow-up at 9 years, 
compared with donor twins if treated with amnioreductions. There were similar 
differences between TTTS twins in the laser treated group, although of minor 
significance.  
6. Despite severe cardiac dysfunction demonstrated in many recipient fetuses, 
almost all variables used to study cardiac structure or function were within 
normal range at a mean age of 4.5 years. 
7. Although laser treatment of TTTS does not seem to completely abolish the risk 
for fetal remodeling of the myocardium, there were no clinically significant 
differences in cardiac function in comparison with healthy singletons.  
 
 
Despite many recipients exhibiting significant cardiac dysfunction during fetal life, 
survivors of TTTS showed only minor within-pair differences in diastolic cardiac 
function at follow-up, and these differences were even smaller in the laser treated 
cohort. Cardiac function in TTTS twins compared well with gender- and age-matched 
controls. Our data agrees with previous studies, suggesting that changes seen in fetal 
hearts of many recipients are reversible [28, 72, 73]. As our findings are based on a 
limited number of TTTS twins, TTTS survivors are few, and echocardiography is a 
harmless method, we suggest that a cardiac screening including an exercise test in late 
childhood should be considered for this group.  
 
Laser treatment has been reported to reduce the intrauterine growth discordance 
between donor and recipient from treatment to birth [74]. In concordance with another 
long-term study of laser treated TTTS infants [75], donors in the laser treated cohort of 
Paper IV were significantly smaller at follow-up than their recipient co-twins and age-
matched controls, despite some catch-up after birth. In the cohort treated with 
amnioreductions (Paper II), the intra-pair difference in growth was not significant at 
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school-age, which may be explained by a less severe TTTS, with the vast majority 
classified as Quintero stages I-II.  
 
Impaired fetal growth has been suggested to result in a deficient synthesis of elastin in 
the walls of the aorta and other large arteries, leading to permanent changes in the 
mechanical properties of these vessels [76]. Loss of natural elasticity has been proposed 
to contribute to an increased BP at older age [77]. In Paper I, we reported narrower 
carotid arteries with higher strain in donors compared with recipients. Being born SGA 
seems to be a risk factor for increased carotid stiffness at school-age [63]. In the MZ 
group without TTTS, the lighter twin demonstrated a higher strain of abdominal aorta, 
but no differences in dimensions or in stiffness index. These differences may be 
explained by donors being exposed not only to intrauterine growth retardation but also 
to hypotension and prematurity. Prematurity has been suggested to be a risk factor for 
aortic narrowing [78], but not for carotid stiffness [79]. A possible long-term 
importance of our findings in TTTS infants compared with non TTTS 
 
Systemic impairment of endothelial function has been found in newborns, children and 
young adults with low birth weight [63, 80]. The finding of impaired response of 
vasodilation to acetylcholine in the smaller MZ twin without TTTS as compared with 
the twin with a greater birth weight, could not be repeated for the MZ twins with TTTS. 
This may be due to shorter gestation of TTTS twins (four pairs were delivered before 
32 weeks), as preterm delivery has been suggested to attenuate developmental 
programming of the endothelium [81].   
 
We also found that MZ twins without TTTS born SGA demonstrated higher BP than 
their siblings born AGA (Paper I). In contrast, there was no difference in SBP between 
TTTS twins, and two donors and two recipients had values above the 90
th
 percentile. 
Although recipients were born AGA, they had been exposed to abnormal circulatory 
load during fetal life, and recipients have showed an increased BP in the neonatal 
period compared with donors [53, 54]. Furthermore, children of preeclamptic mothers 
have developed increased BP and BMI in childhood or young adulthood according to a 
recent review article [82]. In our study group, maternal preeclampsia was found to be a 
contributor to within-pair BP differences in SBP, suggesting that preeclampsia 
somehow adds to the circulatory stress during pregnancy and may not be only of 
genetic origin.   
  
None of the laser treated twins assessed in Paper IV showed any ventricular 
hypertrophy at follow-up. Interestingly, we found the dimensions of the right and left 
ventricular outflow tracts and longitudinal diameters to be smaller in both donors and 
recipients compared with age- and gender-matched controls. Discordance in body size 
could in this regard only be an explanation for the donor group, as recipients’ body 
sizes did not deviate significantly from those of controls. Furthermore, we did not 
observe any differences in LVOT/RVOT ratios, and all outflow velocities were within 
normal range and similar between groups. Recently, Lewandowski et al reported larger 
mass, shorter longitudinal diameter and impaired systolic and diastolic strain of left 
ventricle in adults born preterm, measured with magnetic resonance tomography [83]. 
Cardiac remodeling has also been studied in lamb models, showing a switch from fetal 
hyperplasia to postnatal hypertrophy of cardiomyocytes at birth occurring regardless of 
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gestational age [84, 85]. Immature cardiomyocytes in the preterm may exhibit early 
remodeling based on exposure of an early increase in after load at birth [86]. 
Albeit statistically significant, the actual differences in ventricular size were very small 
and our findings of lack of differences in ventricular wall thickness or outflow 
obstruction are probably of greater clinical importance. 
 
We have reported a lower rate of neonatal survival in the laser treated TTTS cohort 
when comparing with extremely preterm born neonates of the population-based 
EPRESS (Extremely Preterm infants in Sweden) study [87]. Monochorionic twins are 
known to demonstrate a worse perinatal outcome than singletons [88]. We speculate 
that a newborn with the combination of TTTS and an extremely preterm birth may 
demonstrate a vulnerability and morbidity comparable to a neonate born at least one 
week earlier. Accordingly, to improve the neonatal care and survival, information of a 
TTTS history, irrespective of treatment, has to be given to the neonatal team. Overall 
survival or neonatal morbidity did not differ significantly between donors and 
recipients except as regards the need for treatment with mechanical ventilation during 
neonatal stay and temporary pulmonary hypertension, which was more common among 
recipients. When considering the high rates of lung disease, e.g. RDS and pulmonary 
hypertension, the neonatal team has to prepare for treatment of these complications in 
two neonates. 
Although preterm male neonates are known to be more vulnerable to neonatal disease 
than females [89], we found no correlation between gender and survival or neonatal 
disease in our TTTS twins. 
 
In our studies we did not identify any infant diagnosed with a duct-dependent right 
ventricular outflow obstruction. However, based on the risk of right ventricular 
hypertrophy with a possible development of outflow obstruction in the recipient fetus, 
the neonatal staff needs to be prepared for an early echocardiographic assessment and 
possible PGE1-infusion at birth.  
 
6.1.1 Methodological considerations 
There are some limitations of these studies as regards methods. One is the dependence 
of reliable pediatric reference data of cardiac measurements when calculating the z-
scores of the study groups. Normative data are included in most software of 
echocardiographic equipment and we primarily used data from Daubeney, Eidem and 
Pettersen [66-68]. In Paper II, three donors and three recipients had tricuspid valve 
areas below the normal range (z-score < -2.0) according to Daubeney. When comparing 
these values with data presented by Pettersen, we found all tricuspid valve areas to be 
within normal range. To manage this, we introduced an age- and gender-matched 
control group in our following study (Paper IV). Echocardiographic measurements do 
not relate simply to measurement of the size of heart structures. Normal values of 
functional data, e.g. conventional Doppler and tissue Doppler data, also change across 
the pediatric age range, and are influenced by patient age [68, 90] and heart rate [90]. In 
our echocardiographic studies, we tried to keep the child calm and confident, watching 
a video in the lap of a parent, to get assessments and heart rates at rest. All children of 
Paper I and IV demonstrated normal heart rate for age according to reference data[91].   
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Usage of speckle tracking echocardiography is highly dependent on the 2D image 
quality and frame-rate. In our attempts to visualize the borders of left and right 
ventricles in the same clip from a longitudinal apical four-chamber view, we sometimes 
experienced software limitations when tracing the right ventricular free wall. VVI-
analyses in a few children were therefore made on different clips for assessments of 
right and left ventricle respectively. Furthermore, data on longitudinal strain has been 
reported to show a higher reproducibility than data on radial strain [92], and we 
therefore chose to report only longitudinal values on strain and strain rate. 
 
Multiple comparisons performed in the echocardiographic studies increased the 
likelihood of statistically significant differences due to random rather than systematic 
variation. However, our finding of a difference in ventricular relaxation within pairs 
was robust: it was found using two independent methods (Doppler flow velocimetry 
and tissue imaging) with reassuringly low p-values (Paper II) and similar results were 
reproduced in the laser treated group (Paper IV). Moreover, the findings of Papers II 
and IV were not confounded or modified by preeclampsia (as in Paper I) or by maternal 
smoking in pregnancy [78]. 
 
6.1.2 Strengths and limitations 
The major strengths of this thesis are the long-term follow-up of cardiac and vascular 
structure and function (Papers I, II and IV) and the high participation rates. The 
prospectively collected cohorts of the studies may have contributed to the high 
participation rate. Even though there are several studies of TTTS fetuses describing 
cardiac findings, we have not been able to identify any other study with a mean age 
past 21 months [73]. All cardiac assessments were performed by a skilled 
echotechnician, blinded to TTTS status.  
 
Limitations to consider with all our studies are the small sample sizes with insufficient 
power to detect small within-pair differences. The relatively limited number of children 
in the different studies is based on the fact that pronounced TTTS is a rare complication 
of MC pregnancies. Moreover, despite the last decades’ increased consciousness of 
TTTS among ultrasonographers, we believe that some TTTS gestations might have 
been undiscovered during the study time and therefore lost for possible treatment 
(Paper III) and follow-up (Paper I-IV).  
 
Misclassifications: 
Only a limited number of placentas of the pregnancies studied in Paper III were sent for 
histopathology. For that reason, we could not determine the success rate of the laser 
coagulation therapy. All units delivering laser treated TTTS pregnancies need to be 
better informed of the importance of sending placentas for analyses to gain further 
experience. 
 
In studies III and IV, we identified donor and recipient status from reports of fetal 
sonography and delivery units. In those few cases where data on phenotype was 
missing in delivery and neonatal records, we chose to define the smallest twin as the 
donor. The accuracy of defining donor and recipient status during fetal monitoring and 
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after birth and whether antenatal ultrasound could predict birth order in twin pregnancy 
has been questioned [93]. Caesarean section is associated with an even greater 
inaccuracy of prediction. Moreover, reversal of the donor-recipient phenotype has been 
suggested to occur in about 5 % of TTTS pregnancies and although some of the 
reported cases have been associated with aneuploidy or genetic disorders, the 
pathophysiology is still unclear and could possibly also occur after laser treatment [94]. 
 
Single survivors: 
Our objective was to study environmental influence on cardiac function by comparing 
twins with identical genotypes (Papers II and IV). In these studies, we excluded twin 
pairs with only one survivor and the results can therefore not be generalized to single 
TTTS survivors. However, since fetal demise of one twin will discontinue the inter-
twin transfusions, we could hypothesize that aside from a probable immediate pressure 
fall including a risk for cerebral damage, the surviving twin will experience a 
normalizing placental circulation. Accordingly, we suggest that single survivors may 
not exhibit a worse cardiac outcome than twins of dual survival. In Paper III, the 
outcome of all twins was reported and in the planned neurodevelopmental follow-up of 
this cohort, twins of dual as well as of single survival will be included.  
 
Neurodevelopmental outcome after TTTS: 
When evaluating possible adverse effects of fetal interventions, neurodevelopmental 
follow-up is recommended. There are several studies on long-term neurodevelopmental 
outcome in early childhood. The rate of neurological late complications after TTTS has 
been reported to be 6 % for severe and 7 % for mild deficits in a study by Graef [95], 
whereas others have stated an incidence of 7 % for cerebral palsy and 17 % for all 
neurological late complications [96]. Wagner et al reported on a better 
neurodevelopmental long-term outcome even in milder TTTS stages (grade I) treated 
with lasercoagulation compared with conservative treatment. However, there was no 
statistical difference in perinatal survival between groups [97]. In a meta-analysis of 
TTTS outcome [98], the pooled analysis confirmed that the risk of cerebral injury was 
not related to twin type (donors 9 %, recipients 10 %, p=0.66). The same author 
reported no possibility to analyze whether survival rates and neurological morbidity 
were related to gestational age at diagnosis and stage of disease. We have not studied 
neurologic outcome in the laser treated cohort, although this is planned for the future, 
but we found the rate of neonatal cerebral injury diagnosed with ultrasonography to be 
14 % among liveborn donors and 6.5 % among recipients (Paper III). In the laser 
treated group of dual survivors assessed with echocardiography (Paper IV), parents 
reported two children (both donors) with a diagnosis of cerebral palsy.  
 
6.2 ETHICAL CONSIDERATIONS 
There are several issues to consider before deciding about delivering TTTS twins 
preterm. First, fetoscopic laser treatment can be performed until 26 weeks of gestation, 
and if this has not been done earlier and there are no contraindications, it may be 
preferred. Second, depending on the degree of abnormalities of Doppler flows in 
umbilical artery, the risk for fetal demise may exceed the risk for an early neonatal 
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death if born extremely preterm. In Paper III, we reported that no donor and only two 
recipients survived delivery before gestational week 26
+0
. This ought to be taken into 
consideration before a delivery at that time is accomplished on fetal indication because 
of the donor. Third, an extremely preterm delivery due to a recipient fetus 
demonstrating cardiac dysfunction, could result in a higher risk for death or more 
severe neonatal complications than if waiting a few weeks. As long as ventricular 
hypertrophy and dysfunction only involves the right side, the myocardial alterations 
seem to be reversible. Despite almost half of the recipients demonstrating fetal 
myocardial hypertrophy, there was only one of all children studied in Papers II and IV 
who developed a pulmonary stenosis requiring surgery.  
 
The median gestational age at laser therapy was 21 (range 17-26) weeks. We found that 
outcome was not related to gestational age at treatment. Experience and skills of the 
team performing laser treatment are probably the most important factors for fetal 
survival [99, 100]. Laser therapy may not be scattered over too many centers, and the 
suggestion has been made to centralize it to a few centers of excellence, where 
treatment of at least twenty TTTS pregnancies per year could be expected [44]. In 
Sweden, that number has been achieved at Karolinska University Hospital during the 
last couple of years. But we could still expect an improvement in outcome due to a 
learning curve. 
 
6.3 FUTURE PERSPECTIVES AND CHALLENGES 
The etiology of TTTS is still unknown and cannot so far be prevented. Although it is a 
rare condition, with a better awareness about characteristic fetal signs of the syndrome 
among midwifes and obstetricians, more TTTS gestations may be eligible for 
evaluation and treatment in specialized centers for fetal interventions. The findings that 
fetal ventricular hypertrophy of the recipient seems to be reversible, have to be 
considered before decision of delivery, especially if the alternative is delivering two 
extremely preterm babies. On the other hand, the hemodynamics of the donor are 
frequently impaired and severe Doppler changes of umbilical vessels are more often the 
reason for an early caesarean section. The decisions of trading one growth retarded 
donor and a pressure loaded recipient for two preterm twins is difficult. With our 
current results, we suggest a desisting from delivery before 28 gestational weeks, if 
possible.  
From the results of Paper III we learnt that TTTS preterms are more exposed to severe 
neonatal complications than other twins or singletons of the same gestational age. This 
is important information to the perinatal teams preparing to take care of these babies. 
The high rate of treatment with mechanical ventilation may suggest that TTTS 
pregnancies < 32 gestational weeks are to be delivered in a tertiary neonatal intensive 
care unit. 
 
The within-pair difference in diastolic function, in favor of the donor, may be a reason 
for echocardiographic controls not only in childhood, but also later in life as teenagers 
or adults. To investigate early signs of impaired cardiac function, recipients might also 
perform an exercise test. All children had normal BP, at the time of the study, but since 
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growth restriction, prematurity and myocardial dysfunction are risk factors for 
hypertension, donors as well as recipients could benefit from BP controls in later life. 
Severe fetal growth retardation contributes to higher blood pressure, arterial narrowing 
and endothelial dysfunction in monozygous twins in childhood.  
 
Increases in the thickness of the intima and media of the carotid artery, as measured 
noninvasively by ultrasonography, are known to be directly associated with an 
increased risk of myocardial infarction and stroke in older adults [101]. In Paper I, we 
reported that donors had a significantly narrower common carotid artery than their 
recipient twins. To our knowledge, there is no data on carotid intima- media thickness 
(IMTc) in TTTS children. We have ultrasound data of IMTc of the TTTS children and 
controls examined for Paper IV and intend to investigate if donors exhibit an increased 
thickness compared with the other groups.  
 
The high risk for preterm birth after treatment for TTTS is a major problem. Premature 
rupture of membranes and bleedings were the most reported complications in the study 
group of Paper III. There is no evidence for cervical cerclage, tocolysis or Arabin 
pessary having been used for prolonging pregnancy in laser treated TTTS pregnancies 
with short cervical length [102]. At present, there are no effective methods to prevent a 
preterm birth if started spontaneously with labor, but progesterone has been suggested 
to be used for primary prevention if there are risk factors for prematurity or for 
secondary prevention after tocolysis [103], although no benefit from progesterone has 
been demonstrated in twin pregnancies [104]. 
 
The results of this thesis demonstrate that despite a fetal cardiovascular distress when 
exposed to TTTS in utero, survivors of laser treated TTTS have a favorable long-term 
cardiac outcome. However, increasing perinatal survival after laser treatment is a 
challenge. In January 2013, a Swedish national workshop was held in Stockholm, 
aiming to increase the knowledge about TTTS and to suggest guidelines. A new 
website was presented to be used as an internet-based platform with information of 
diagnosis, surveillance, treatment, follow-up and current research.  
Increased knowledge about how to characterize TTTS when assessing MC pregnancies 
with ultrasonography and Doppler, may improve possibilities for early treatment and 
close surveillance, and also to adequately inform prospective parents.  
An extended follow-up program has been introduced for extremely preterm born 
children, including neurodevelopmental testing, blood pressure monitoring and 
evaluation of respiratory function. Based on the high perinatal morbidity, this program 
may be suggested for TTTS twins irrespective of gestational age at birth.  
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7 SVENSK SAMMANFATTNING 
Bakgrund: 
Tvillinggraviditeter utgör 1-3 % av alla graviditeter och av dessa är en tredjedel 
enäggstvillingar och två tredjedelar tvåäggstvillingar. Om enäggstvillingarna delar 
samma moderkaka är risken 10 % att ett tvillingtransfusionssyndrom (TTS) utvecklas. 
Den ena tvillingen (givaren) kommer via gemensamma kärl i moderkakan att förlora en 
del av sin blodvolym. Blodmängden förs istället över till den andra tvillingen 
(mottagaren). Den ojämna blodfördelningen medför risker för såväl givare som 
mottagare att bli cirkulatoriskt påverkade och dö. Dödligheten vid obehandlad TTS är 
ca 80%, men idag behandlas tillståndet med laserkoagulering av kärlförbindelserna. 
Enäggstvillingar är genetiskt identiska, vilket ger en unik möjlighet att studera hur 
olikheter i fostermiljön kan påverka tvillingarnas utveckling, inte minst vad gäller hjärt-
kärlfunktion. Denna avhandling har flera syften: 1) att utvärdera om det vid 8 års ålder 
finns skillnader i blodtryck och kärlfunktion mellan tvillingsyskon som haft olika 
födelsevikt pga olika fostertillväxt (delstudie I); 2) att studera om det finns tecken till 
långtidseffekter av TTS på hjärtats struktur och funktion (delstudier II och IV); 3) att 
rapportera överlevnad och sjuklighet i nyföddhetsperioden för den grupp kvinnor som 
genomgått laserbehandling i Sverige pga TTS (delstudie III). 
Metoder och resultat: 
I delstudie I undersökte vi 31 tvillingpar i 8-årsåldern från enäggsgraviditeter med och 
utan TTS samt från tvåäggsgraviditeter. I varje tvillingpar var en tvilling född lätt-för-
tiden och den andra normalstor-för-tiden. Vi fann i gruppen enäggstvillingar bl a att 
blodtrycket var högre hos den tvilling som haft den lägsta födelsevikten.  
I delstudie II undersökte vi hjärtat med ultraljud hos elva 9-åriga TTS-par, som under 
fostertiden genomgått fostervattentappningar. Den enda skillnaden vi fann mellan 
respektive tvilling var att mottagarna hade något sämre kammarfyllnad jämfört med 
sina givarsyskon. När vi därefter i delstudie IV undersökte nitton TTS-par vid 4,5 års 
ålder, som genomgått laser behandling under fostertiden, fann vi något mindre uttalade 
men snarlika skillnader i hjärtats kammarfyllnad. I delstudie III gick vi igenom 
journaldata från alla TTS-graviditeter som behandlats med laser (71 kvinnor).Vi fann 
bland annat att överlevnaden från behandling till ett års ålder var 46 %, den 
genomsnittliga graviditetslängden var 30 veckor och hälften av de levande födda 
tvillingarna krävde respiratorbehandling. 
Slutsatser: 
Dålig fostertillväxt kan bidra till högre blodtryck, smalare blodkärl och nedsatt förmåga 
att vidga blodkärlen i barndomen (delarbete 1). Trots att TTS foster, i synnerhet 
mottagartvillingar, ofta har ett belastat hjärta med bland annat förtjockade 
hjärtmuskelväggar, hade TTS tvillingarna i våra studier väsentligen normal 
hjärtfunktion i tidig barndom. De milda tecken på sämre kammarfyllnad som förelåg 
bland mottagartvillingar som behandlats med fostervattentappningar, i jämförelse med 
givarsyskonen (delarbete II), var mindre uttalade i den laserbehandlade gruppen 
(delarbete IV). Ungefär hälften av de tvillingfoster som genomgår laserkoagulering av 
kärlförbindelser i moderkakan vid TTS lever vid ett års ålder. Om mycket för tidig 
förlossning är nödvändig, bör det mottagande teamet förbereda sig för att ta hand om 
två svårt sjuka nyfödda som ofta kräver respiratorvård (delarbete III).  
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